UnitedHealth Group Incorporated $UNH Shares Bought by Obermeyer Wealth Partners

Obermeyer Wealth Partners grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 49.3% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,337 shares of the healthcare conglomerate’s stock after purchasing an additional 37,435 shares during the period. UnitedHealth Group makes up about 1.8% of Obermeyer Wealth Partners’ holdings, making the stock its 20th largest holding. Obermeyer Wealth Partners’ holdings in UnitedHealth Group were worth $35,358,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Freestone Capital Holdings LLC raised its stake in shares of UnitedHealth Group by 39.4% in the second quarter. Freestone Capital Holdings LLC now owns 33,040 shares of the healthcare conglomerate’s stock valued at $10,308,000 after acquiring an additional 9,332 shares in the last quarter. Seelaus Asset Management LLC increased its holdings in UnitedHealth Group by 11.7% in the second quarter. Seelaus Asset Management LLC now owns 1,047 shares of the healthcare conglomerate’s stock valued at $327,000 after buying an additional 110 shares during the last quarter. BCGM Wealth Management LLC increased its holdings in UnitedHealth Group by 59.0% in the second quarter. BCGM Wealth Management LLC now owns 6,355 shares of the healthcare conglomerate’s stock valued at $1,983,000 after buying an additional 2,359 shares during the last quarter. Tsfg LLC increased its holdings in UnitedHealth Group by 10.0% in the second quarter. Tsfg LLC now owns 572 shares of the healthcare conglomerate’s stock valued at $179,000 after buying an additional 52 shares during the last quarter. Finally, Westside Investment Management Inc. increased its holdings in UnitedHealth Group by 17.2% in the second quarter. Westside Investment Management Inc. now owns 4,016 shares of the healthcare conglomerate’s stock valued at $1,254,000 after buying an additional 589 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on UNH. Barclays increased their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Bank of America raised their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Mizuho raised their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a report on Wednesday, October 29th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $341.46 on Monday. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a market cap of $309.31 billion, a P/E ratio of 17.82, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a 50-day moving average price of $343.51 and a 200 day moving average price of $325.81.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period last year, the company posted $7.15 EPS. The company’s revenue was up 12.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.